In the long run, Biolase Inc (BIOL) Stock makes the most sense financially and strategically
The Benchmark Company raised the price target for the Biolase Inc (NASDAQ:BIOL) stock to “a Speculative buy”. The rating was released on June 19, 2019, according to finviz. The research report from WallachBeth has downgraded the stock from Buy to Hold, with a price target set at $2.50. The stock was reiterated by WallachBeth, who […]
The market value of Biolase Inc (BIOL) Stock is expected to soar in the coming months
The Benchmark Company raised the price target for the Biolase Inc (NASDAQ:BIOL) stock to “a Speculative buy”. The rating was released on June 19, 2019, according to finviz. The research report from WallachBeth has downgraded the stock from Buy to Hold, with a price target set at $2.50. The stock was reiterated by WallachBeth, who […]
What’s best: jumping in or staying out? Biolase Inc (BIOL) Stock
The Benchmark Company raised the price target for the Biolase Inc (NASDAQ:BIOL) stock to “a Speculative buy”. The rating was released on June 19, 2019, according to finviz. The research report from WallachBeth has downgraded the stock from Buy to Hold, with a price target set at $2.50. The stock was reiterated by WallachBeth, who […]
Biolase Inc (BIOL) Stock is expected to generate profits in the near future
The Benchmark Company raised the price target for the Biolase Inc (NASDAQ:BIOL) stock to “a Speculative buy”. The rating was released on June 19, 2019, according to finviz. The research report from WallachBeth has downgraded the stock from Buy to Hold, with a price target set at $2.50. The stock was reiterated by WallachBeth, who […]
Offering unique exposure at competitive prices: Biolase Inc (BIOL) Stock
The Benchmark Company raised the price target for the Biolase Inc (NASDAQ:BIOL) stock to “a Speculative buy”. The rating was released on June 19, 2019, according to finviz. The research report from WallachBeth has downgraded the stock from Buy to Hold, with a price target set at $2.50. The stock was reiterated by WallachBeth, who […]
Will Earnings Beat Estimates? Biolase Inc (BIOL) Stock
The Benchmark Company raised the price target for the Biolase Inc (NASDAQ:BIOL) stock to “a Speculative buy”. The rating was released on June 19, 2019, according to finviz. The research report from WallachBeth has downgraded the stock from Buy to Hold, with a price target set at $2.50. The stock was reiterated by WallachBeth, who […]
There Is Nothing Like Biolase Inc (BIOL) Stock
The Benchmark Company raised the price target for the Biolase Inc (NASDAQ:BIOL) stock to “a Speculative buy”. The rating was released on June 19, 2019, according to finviz. The research report from WallachBeth has downgraded the stock from Buy to Hold, with a price target set at $2.50. The stock was reiterated by WallachBeth, who […]
